238 related articles for article (PubMed ID: 24299557)
1. The human liver fatty acid binding protein T94A variant alters the structure, stability, and interaction with fibrates.
Martin GG; McIntosh AL; Huang H; Gupta S; Atshaves BP; Landrock KK; Landrock D; Kier AB; Schroeder F
Biochemistry; 2013 Dec; 52(51):9347-57. PubMed ID: 24299557
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional interaction of fatty acids with human liver fatty acid-binding protein (L-FABP) T94A variant.
Huang H; McIntosh AL; Martin GG; Landrock KK; Landrock D; Gupta S; Atshaves BP; Kier AB; Schroeder F
FEBS J; 2014 May; 281(9):2266-83. PubMed ID: 24628888
[TBL] [Abstract][Full Text] [Related]
3. Human FABP1 T94A variant impacts fatty acid metabolism and PPAR-α activation in cultured human female hepatocytes.
McIntosh AL; Huang H; Storey SM; Landrock KK; Landrock D; Petrescu AD; Gupta S; Atshaves BP; Kier AB; Schroeder F
Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G164-76. PubMed ID: 24875102
[TBL] [Abstract][Full Text] [Related]
4. High glucose potentiates L-FABP mediated fibrate induction of PPARα in mouse hepatocytes.
Petrescu AD; McIntosh AL; Storey SM; Huang H; Martin GG; Landrock D; Kier AB; Schroeder F
Biochim Biophys Acta; 2013 Aug; 1831(8):1412-25. PubMed ID: 23747828
[TBL] [Abstract][Full Text] [Related]
5. Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias.
Schroeder F; McIntosh AL; Martin GG; Huang H; Landrock D; Chung S; Landrock KK; Dangott LJ; Li S; Kaczocha M; Murphy EJ; Atshaves BP; Kier AB
Lipids; 2016 Jun; 51(6):655-76. PubMed ID: 27117865
[TBL] [Abstract][Full Text] [Related]
6. Molecular differences between human liver fatty acid binding protein and its T94A variant in their unbound and lipid-bound states.
D'Onofrio M; Barracchia CG; Bortot A; Munari F; Zanzoni S; Assfalg M
Biochim Biophys Acta Proteins Proteom; 2017 Sep; 1865(9):1152-1159. PubMed ID: 28668637
[TBL] [Abstract][Full Text] [Related]
7. Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein.
Wolfrum C; Ellinghaus P; Fobker M; Seedorf U; Assmann G; Börchers T; Spener F
J Lipid Res; 1999 Apr; 40(4):708-14. PubMed ID: 10191295
[TBL] [Abstract][Full Text] [Related]
8. Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate.
Brouillette C; Bossé Y; Pérusse L; Gaudet D; Vohl MC
J Hum Genet; 2004; 49(8):424-432. PubMed ID: 15249972
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoid Interaction with Human FABP1: Impact of the T94A Variant.
Martin GG; Huang H; McIntosh AL; Kier AB; Schroeder F
Biochemistry; 2017 Sep; 56(38):5147-5159. PubMed ID: 28853554
[TBL] [Abstract][Full Text] [Related]
10. L-FABP directly interacts with PPARalpha in cultured primary hepatocytes.
Hostetler HA; McIntosh AL; Atshaves BP; Storey SM; Payne HR; Kier AB; Schroeder F
J Lipid Res; 2009 Aug; 50(8):1663-75. PubMed ID: 19289416
[TBL] [Abstract][Full Text] [Related]
11. Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator-activated receptor-alpha activity in cultured primary hepatocytes.
McIntosh AL; Atshaves BP; Hostetler HA; Huang H; Davis J; Lyuksyutova OI; Landrock D; Kier AB; Schroeder F
Arch Biochem Biophys; 2009 May; 485(2):160-73. PubMed ID: 19285478
[TBL] [Abstract][Full Text] [Related]
12. Human FABP1 T94A variant enhances cholesterol uptake.
Huang H; McIntosh AL; Landrock KK; Landrock D; Storey SM; Martin GG; Gupta S; Atshaves BP; Kier AB; Schroeder F
Biochim Biophys Acta; 2015 Jul; 1851(7):946-55. PubMed ID: 25732850
[TBL] [Abstract][Full Text] [Related]
13. Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha.
Kockx M; Gervois PP; Poulain P; Derudas B; Peters JM; Gonzalez FJ; Princen HM; Kooistra T; Staels B
Blood; 1999 May; 93(9):2991-8. PubMed ID: 10216095
[TBL] [Abstract][Full Text] [Related]
14. Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus.
Wolfrum C; Borrmann CM; Borchers T; Spener F
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2323-8. PubMed ID: 11226238
[TBL] [Abstract][Full Text] [Related]
15. Impact of L-FABP and glucose on polyunsaturated fatty acid induction of PPARα-regulated β-oxidative enzymes.
Petrescu AD; Huang H; Martin GG; McIntosh AL; Storey SM; Landrock D; Kier AB; Schroeder F
Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(3):G241-56. PubMed ID: 23238934
[TBL] [Abstract][Full Text] [Related]
16. L-FABP T94A decreased fatty acid uptake and altered hepatic triglyceride and cholesterol accumulation in Chang liver cells stably transfected with L-FABP.
Gao N; Qu X; Yan J; Huang Q; Yuan HY; Ouyang DS
Mol Cell Biochem; 2010 Dec; 345(1-2):207-14. PubMed ID: 20721681
[TBL] [Abstract][Full Text] [Related]
17. Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine.
Poirier H; Niot I; Monnot MC; Braissant O; Meunier-Durmort C; Costet P; Pineau T; Wahli W; Willson TM; Besnard P
Biochem J; 2001 Apr; 355(Pt 2):481-8. PubMed ID: 11284737
[TBL] [Abstract][Full Text] [Related]
18. Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator-activated receptor-alpha-dependent.
Landrier JF; Thomas C; Grober J; Duez H; Percevault F; Souidi M; Linard C; Staels B; Besnard P
J Biol Chem; 2004 Oct; 279(44):45512-8. PubMed ID: 15337740
[TBL] [Abstract][Full Text] [Related]
19. Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepatocytes -- role of the peroxisome proliferator-activated receptor-alpha.
Kockx M; Princen HM; Kooistra T
Thromb Haemost; 1998 Dec; 80(6):942-8. PubMed ID: 9869165
[TBL] [Abstract][Full Text] [Related]
20. Human Liver Fatty Acid Binding Protein-1 T94A Variant, Nonalcohol Fatty Liver Disease, and Hepatic Endocannabinoid System.
Martin GG; Landrock D; Dangott LJ; McIntosh AL; Kier AB; Schroeder F
Lipids; 2018 Jan; 53(1):27-40. PubMed ID: 29488637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
